Anti-thymocyte globulin (ATG) Clinical Trials
2 recruitingDrug
Phase 22Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Type 1 DiabetesNew Onset
City of Hope Medical Center120 enrolled11 locationsNCT07061574
Recruiting
Phase 2
Precision Administration of Anti-thymocyte Globulin With or Without Verapamil
Type 1 Diabetes
University of Florida60 enrolled2 locationsNCT06455319